# Study on Yangxue Nao Granules Reducing the Risk of Stroke

> **NCT04949906** · — · COMPLETED · sponsor: **Peking University Third Hospital** · enrollment: 150 (actual)

## Conditions studied

- Cerebral Infarction

## Interventions

- **DRUG:** Raise serum brain granules
- **DRUG:** No nourishing serum brain granules are used

## Key facts

- **NCT ID:** NCT04949906
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-01
- **Primary completion:** 2020-09-01
- **Final completion:** 2020-11-01
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2021-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04949906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04949906, "Study on Yangxue Nao Granules Reducing the Risk of Stroke". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04949906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*